Monte Rosa Therapeutics

Monte Rosa Therapeutics

https://www.monterosatx.com/
Tags:BiopharmaBioTechChemicalDesignDrugEnterpriseITPlatformProductResearch
Small molecule protein degraders are set to reshape the way by which diseases will be treated. Our rational approach in targeting disease-causing proteins for degradation will deliver pioneering therapies for cancer and beyond. Headquartered in Boston with additional laboratory facilities in Basel, Monte Rosa Therapeutics is a private company launched in 2020. Initially seeded by Versant Ventures and incubated at Ridgeline Discovery in Basel, and The Institute of Cancer Research in London, Monte Rosa has raised $32.5 million from Versant and New Enterprise Associates. Academic co-founders are Prof. Raj Chopra and Prof. Ian Collins of The Institute for Cancer Research, UK.
Location: United States, Massachusetts, Boston
Member count: 11-50
Total raised: $445.5M

Investors 4

Funding Rounds 4

DateSeriesAmountInvestorsDeal News
25.06.2021IPO$222M--
12.03.2021Series C$95M--
24.09.2020Series B$96M--
27.05.2020Series A$32.5MNew Enterp...-

Mentions in press and media 22

DateTitleDescriptionCategoryAuthorSource
04.02.2022Monte Rosa...BOSTON, Feb. 03, 2022 (GLOBE N...--marketscre...
10.11.2021Monte Rosa...– Initiated Investigational Ne...--marketscre...
25.06.2021Monte Rosa... After VectivBio, Gain Therap...Financing-startuptic...
25.06.2021Monte Rosa...After VectivBio, Gain Therapeu...IPO-startuptic...
19.03.2021Monte Rosa... Monte Rosa was launched from...Financing-startuptic...
19.03.2021Monte Rosa...Monte Rosa was launched from f...Investment-startuptic...
16.03.2021Monte Rosa...Monte Rosa Therapeutics, a Bos...USA-finsmes.co...
15.03.2021Monte Rosa...Monte Rosa Therapeutics has ra...--pitchbook....
12.03.2021Monte Rosa...BOSTON, MA – March 12, 2021 – ...--aislingcap...
12.03.2021Monte Rosa...Monte Rosa Therapeutics is at ...Biotech-fiercebiot...
Show more